Navigation Links
DHA Hailed as Breakthrough Treatment for Lowering Risk of Developmental Disorders in Premature Infants; Animi-3(R) Prescribed to Women Who Are Not Eating Fish
Date:1/19/2009

GORDONSVILLE, Va., Jan. 19 /PRNewswire/ -- Findings published in the Journal of the American Medical Association (JAMA) have demonstrated high doses of DHA-dominant omega-3 fatty acids administered to premature infants via their mother's breast milk can reduce the risk of developmental disorders.

In a six-year study involving 657 premature infants, researchers found the lipid DHA is not developed sufficiently in premature infants, leading to possible impaired mental development. To offset this omega-3 deficiency, 1000mg DHA supplements were given to lactating mothers with pre-term infants; some infants were fed supplemental infant formula with matching DHA levels.

Approximately 50 percent fewer infants on high-DHA diets experienced delayed mental development compared to infants on low-DHA diets. Infants weighing one-third the weight of a full-term baby who were fed high-DHA diets scored better on mental development tests, with a 40 percent reduction in the incidence of mild mental delay.

"My studies have shown that pregnant and lactating women are not eating fish, which is why a pharmaceutical-grade omega-3 supplement is so important to their daily diets," said Dr. Barbara Levine, Weill Cornell Medical College. "Since women are concerned about contaminants in fish and have difficulty stomaching fish during pregnancy, many doctors are now prescribing Animi-3, a DHA-dominant omega-3 formulation, to make sure they get what they need for baby."

"This new research published in JAMA supports the reasoning behind our prescription supplement with 350mg of DHA," said President Jack Schramm, PBM Pharmaceuticals, Inc., the makers of Animi-3. "Studies continue to highlight the role nutritional deficiencies of the Animi-3 nutrients play in the overall health of adults and their children."

Women are being prescribed Animi-3 by their doctors to address DHA and other nutritional deficiencies in their diets. Each capsule of Animi-3 contains 500 mg of omega-3, (350 mg of DHA), 200 mg of phytosterols, 1 mg of folic acid, 12.5 mg of B6, and 12 mcg of B12.

More information on Animi-3 ingredients is found on www.animi-3.com and on www.dhaandbvitamins.org, a resource developed by specialists at Weill Cornell Medical College and other medical centers.

Animi-3 is not intended to diagnose, treat, or cure any disease.

Source: JAMA. 2009;301(2):175-182

    Contact:  Joe Shields
    Director of Public Relations
    (800) 959-2066 ext. 1131
    jshields@pbmproducts.com


'/>"/>
SOURCE PBM Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
2. Canine Cancer #1 Fear of Dog Lovers, Web Exclusive by Morris Animal Foundation Provides News on Latest Breakthroughs - Crucial Facts for Dog Owners
3. American Asthma Foundation Announces Breakthrough Discovery
4. A breakthrough in diagnosis of enteric lesions
5. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
6. DR. MIRACLES Wins 2008 WWD Beauty Biz Award: Breakthrough Product of the Year!!!
7. Res-Q Gains Rights To Market Orosine - a Breakthrough, Patented, Natural Heart Supplement That Cardiologists Are Calling the Ultimate Cardio Protection Against Heart Attacks, Strokes and Heart Failure.
8. 50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases
9. Major North American breakthrough for dialysis patients
10. Canadian cold/flu breakthrough remedy undergoes NCI-sponsored trial in leukemia patients
11. Breakthrough in cell-type analysis offers new ways to study development and disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 According to a ... (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, ... Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & ... studies the market for the forecast period of 2016 ... 2.81 Billion by 2021 from USD 1.65 Billion in ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology: